Skip to content
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Menu
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Happy News

Medical Marijuana Got A Major Federal Upgrade

For the first time in more than 50 years, the federal government has fundamentally changed how it classifies medical marijuana, and for millions of patients and researchers, this is a very big deal. Effective April 28, 2026, the Justice Department and the Drug Enforcement Administration officially moved FDA-approved cannabis products and state-licensed medical marijuana from Schedule I to Schedule III of the Controlled Substances Act. Schedule I — the most restrictive category, reserved for substances with “no accepted medical use” — is where marijuana has sat since 1970, alongside heroin. Moving to Schedule III, the same category as ketamine and certain anabolic steroids, is a landmark shift that recognizes what 40 U.S. states have already acknowledged for years: medical marijuana has genuine therapeutic value. For patients, the change could improve access and affordability, as medical cannabis businesses will no longer face a punishing tax rule that had effectively prohibited them from deducting standard business expenses, often pushing effective federal tax rates on those businesses as high as 70 to 80 percent.

For scientists, the rescheduling is equally significant. Schedule I status has long created enormous barriers to cannabis research, making it exceptionally difficult to study a substance tens of millions of Americans already use. Researchers studying everything from chronic pain to epilepsy to PTSD have faced federal restrictions that simply don’t apply to other substances under study. Those barriers will now ease meaningfully. A DEA administrative hearing beginning June 29, 2026, will consider whether the rescheduling extends to all marijuana — including recreational products. For now, the immediate and historic win belongs to the patients, doctors, and researchers who have long argued that science, not stigma, should drive federal drug policy.

Source: https://apnews.com/article/medical-marijuana-rescheduling-justice-department-trump-cannabis-1d6722d3aae122b1a91f8e4b6c690268

PrevPreviousA Pill That Costs Pennies And Has Been Around For 125 Years May Also Fight Cancer

Recent Articles

Happy News

The FDA Just Approved The First Gene Therapy For Inherited Deafness And The Company Is Making It Free

April 27, 2026

The Food and Drug Administration has approved the first ever gene therapy for inherited hearing loss, a one-time treatment developed by Regeneron Pharmaceuticals that has proven life-changing for children born deaf due to a mutation in a gene called OTOF, which the ear needs to transmit sound signals to the

Read More
Happy News

AI Just Discovered New Laws Of Physics That Human Researchers Had Never Found

April 27, 2026

Physicists at Emory University have done something that scientists have been working toward for years: they used artificial intelligence not just to analyze data, but to discover entirely new laws of physics that human researchers had not previously seen. The team focused on dusty plasma, a strange substance sometimes called

Read More
Happy News

Coachella 2026, Here Are The Moments Everyone Is Still Talking About

April 26, 2026

The tents are down, the desert dust has settled, and the internet is still replaying the clips. Coachella 2026 ran April 10 through 19 in Indio, California, and delivered one of the most viral, surprise-packed editions in recent memory. Headliners Sabrina Carpenter, Justin Bieber, and Karol G each brought something

Read More
« Previous Next »
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
Copyright © 2026 HappyNews.